Revolution Medicines Inc (RVMD) — Financial Flexibility Index
Revolution Medicines Inc (RVMD) has a Financial Flexibility Index of -0.47x as of March 2026. Free cash flow of $-352.63 Million (operating CF $-354.17 Million minus capex $1.54 Million) represents 0% of total liabilities ($753.82 Million). Check asset allocation strategy of Revolution Medicines Inc to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Revolution Medicines Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Revolution Medicines Inc across 9 annual periods. See Revolution Medicines Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Revolution Medicines Inc (2017–2025)
Year-by-year free cash flow to debt coverage for Revolution Medicines Inc. For the full company profile including market capitalisation, see Revolution Medicines Inc (RVMD) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.22x | $-881.75 Million | $-897.74 Million | $723.21 Million | ▲ +34.7% |
| 2024 | -1.87x | $-547.13 Million | $-557.44 Million | $293.10 Million | ▼ -28.2% |
| 2023 | -1.46x | $-342.84 Million | $-350.57 Million | $235.51 Million | ▲ +13.6% |
| 2022 | -1.69x | $-213.59 Million | $-224.40 Million | $126.74 Million | ▼ -62.3% |
| 2021 | -1.04x | $-140.65 Million | $-147.18 Million | $135.42 Million | ▲ +0.8% |
| 2020 | -1.05x | $-97.13 Million | $-100.06 Million | $92.72 Million | ▼ -51.5% |
| 2019 | -0.69x | $-47.03 Million | $-49.62 Million | $67.99 Million | ▼ -1985.3% |
| 2018 | 0.04x | $2.71 Million | $1.21 Million | $73.93 Million | ▲ +101.6% |
| 2017 | -2.24x | $-23.57 Million | $-25.15 Million | $10.55 Million | — |